# US 2021/0198730 A1 · Polynucleotide barcodes for long read sequencing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0198730 A1
- Document ID: US20210198730A1
- Status: Published application
- Kind: A1
- Application number: 17/127,514
- Filed: 2020-12-18
- Published: 2021-07-01
- Earliest claimed: 2019-12-31
- Assignees: Singular Genomics Systems, Inc.
- Applicants: Singular Genomics Systems, Inc.
- Inventors: Eli N. GLEZER; Martin Maria FABANI; Ryan SHULTZABERGER; Bharat SRIDHAR; Gudrun STENGEL; Christopher Jen-Yue WEI
- Web page: https://patentgrep.com/patent/US20210198730A1

## CPC

- C12Q 1/6853: using modified primers or templates
- C12Q 1/6869: Methods for sequencing
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Provided herein are methods of making, amplifying, and sequencing tagged nucleic acid complements, compositions including interposing oligonucleotide barcodes, and kits useful in obtaining long-range sequence data.

## Claims

### Claim 1

A method of amplifying tagged complements of a plurality of sample polynucleotides, the method comprising:
a. hybridizing to each of the plurality of sample polynucleotides a plurality of interposing oligonucleotide barcodes, each of the interposing oligonucleotide barcodes comprising from 5′ to 3′:
i. a first hybridization pad complementary to a first sequence of a sample polynucleotide;
ii. a first stem region comprising a sequence common to the plurality of interposing oligonucleotide barcodes;
iii. a loop region comprising a barcode sequence, wherein the barcode sequence, alone or in combination with a sequence of one or both of (a) the sample polynucleotide, or (b) one or more additional barcode sequences, uniquely distinguishes the sample polynucleotide from other sample polynucleotides in the plurality;
iv. a second stem region comprising a sequence complementary to the first stem region, wherein the second stem region is capable of hybridizing to the first stem region under hybridization conditions; and
v. a second hybridization pad complementary to a second sequence of the sample polynucleotide;
b. extending the 3′ ends of the second hybridization pads with one or more polymerases to create extension products; and
c. ligating adjacent ends of extension products hybridized to the same sample polynucleotide thereby making integrated strands comprising complements of the plurality of sample polynucleotides tagged with a plurality of interposing oligonucleotide barcodes; and
d. amplifying the integrated strands by an amplification reaction thereby amplifying the tagged complements of the plurality of sample polynucleotides.

### Claim 2 (depends on 1)

The method of claim 1, wherein each hybridization pad comprises about 9 to about 15 nucleotides.

### Claim 3 (depends on 1)

The method of claim 1, wherein each of the interposing oligonucleotide barcodes comprises a phosphorylated 5′ end.

### Claim 4 (depends on 1)

The method of claim 1, wherein each hybridization pad comprises a targeted primer sequence.

### Claim 5 (depends on 1)

The method of claim 1, wherein the total combined length of the first hybridization pad and the second hybridization pad comprises about 18 to about 25 nucleotides.

### Claim at position 6

-30. (canceled)

### Claim 31 (depends on 1)

The method of claim 1, wherein the second hybridization pad of each interposing oligonucleotide barcode is at least twice as long as the first hybridization pad of each interposing oligonucleotide barcode.

### Claim 32 (depends on 1)

The method of claim 1, wherein the second hybridization pad of each interposing oligonucleotide barcode is about the same length as the first hybridization pad of each interposing oligonucleotide barcode.

### Claim 33 (depends on 1)

The method of claim 1, wherein the barcode sequence comprises about 5 to 15 nucleotides.

### Claim 34 (depends on 1)

The method of claim 1, wherein the first and second stem regions are complementary and wherein each stem region comprises a known sequence of about 5 to about 10 nucleotides.

### Claim 35 (depends on 1)

The method of claim 1, wherein the loop region comprises about 5 to about 20 nucleotides, or about 10 to about 20 nucleotides.

### Claim 36 (depends on 1)

The method of claim 1, wherein the sample polynucleotides comprise a gene or a gene fragment, wherein the gene or gene fragment is a cancer-associated gene or fragment thereof, T cell receptor (TCRs) gene or fragment thereof, or a B cell receptor (BCRs) gene, or fragment thereof.

### Claim 37 (depends on 1)

The method of claim 1, wherein the sample polynucleotides comprise genomic DNA, complementary DNA (cDNA), cell-free DNA (cfDNA), messenger RNA (mRNA), transfer RNA (tRNA), ribosomal RNA (rRNA), cell-free RNA (cfRNA), or noncoding RNA (ncRNA).

### Claim 38 (depends on 1)

The method of claim 1, wherein amplifying comprises hybridizing an amplification primer to the integrated strands and cycles of primer extension with a polymerase and nucleotides to generate amplified products.

### Claim 39 (depends on 1)

The method of claim 1, further comprising hybridizing to each of the plurality of sample polynucleotides a terminal adapter, wherein said terminal adapter comprises a first hybridization pad complementary to a first sequence of a sample polynucleotide, a barcode sequence, and a primer binding sequence.

### Claim 40 (depends on 39)

The method of claim 39, wherein amplifying comprises hybridizing an amplification primer to the primer binding sequence of the terminal adapter and cycles of primer extension with a polymerase and nucleotides to generate amplified products.

### Claim 41 (depends on 1)

The method of claim 1, wherein the amplification reaction comprises polymerase chain reaction (PCR), strand displacement amplification (SDA), multiple displacement amplification (MDA), ligation chain reaction, transcription mediated amplification (TMA), nucleic acid sequence based amplification (NASBA), rolling circle amplification (RCA), exponential rolling circle amplification (eRCA), hyperbranched rolling circle amplification (HRCA), or a combination thereof.

### Claim 42 (depends on 1)

The method of claim 1, wherein amplifying comprises extending an amplification primer with a stand-displacing polymerase at a temperature of about 20° C. to about 50° C.

### Claim 43 (depends on 1)

The method of claim 1, further comprising sequencing the amplified products of step (d).

### Claim 44 (depends on 43)

The method of claim 43, wherein the sequencing comprises: (A) fragmenting the amplified products to produce fragments, (B) ligating adapters to the fragments, (C) amplifying the resultant products from step (B) to generate a polynucleotide, and (D) performing a sequencing reaction on the polynucleotide from step (C).

### Claim 45 (depends on 43)

The method of claim 43, wherein the sequencing further comprises (a) producing a plurality of sequencing reads; (b) grouping sequencing reads based on co-occurrence of barcode sequences; and (c) within each group, aligning the reads that belong to the same strand of an original sample polynucleotide based on the sequences of the barcode sequences.

### Claim 46 (depends on 45)

The method of claim 45, wherein each of the sequencing reads comprise at least a portion of two or more barcode sequences, or complements thereof.

### Claim 47 (depends on 45)

The method of claim 45, wherein aligning the reads comprises alignment to a reference genome.

### Claim 48 (depends on 45)

The method of claim 45, further comprising computationally reconstructing sequences of a plurality of individual strands of original sample polynucleotides by removing interposing oligonucleotide barcode-derived sequences and joining sequences for adjacent portions of the sample polynucleotide.

### Claim 49 (depends on 45)

The method of claim 45, wherein sequencing comprises 20 to 100 sequencing cycles.

### Claim 50 (depends on 45)

The method of claim 45, wherein sequencing comprises 50 to 300 sequencing cycles.

### Claim 51 (depends on 45)

The method of claim 45, wherein the sequencing further comprises forming a consensus sequence for reads having the same interposing oligonucleotide barcode, or a portion thereof.

### Claim 52 (depends on 51)

The method of claim 51, wherein the consensus sequence is obtained by comparing all sequencing reads aligning at a given nucleotide position, and identifying the nucleotide at that position as the one shared by a majority of the aligned reads.

### Claim 53 (depends on 1)

A plurality of tagged complements of a plurality of sample polynucleotides, produced according to the method of claim 1.

### Claim 54 (depends on 1)

The method of claim 1, wherein the tagged complement is at least 1 kb in length.

### Claim 55 (depends on 1)

The method of claim 1, wherein the tagged complement is about 1 to 3 kb, and only a portion of the tagged complement is sequenced at a time.
